|
1
|
Miller KD, Siegel RL, Lin CC, Mariotto AB,
Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer
treatment and survivorship statistics, 2016. CA Cancer J Clin.
66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wale A, Van Cutsem E, Rao S, Cunningham D
and Brown G: Session 2: Synchronous metastatic disease-liver first
or primary first? The oncologist decides. Colorectal Dis. 20 (Suppl
1):S52–S55. 2018. View Article : Google Scholar
|
|
3
|
Loret N, Denys H, Tummers P and Berx G:
The role of epithelial-to-mesenchymal plasticity in ovarian cancer
progression and therapy resistance. Cancers (Basel). 11:E8382019.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blick T, Widodo E, Hugo H, Waltham M,
Lenburg ME, Neve RM and Thompson EW: Epithelial mesenchymal
transition traits in human breast cancer cell lines. Clin Exp
Metastasis. 25:629–642. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bastid J: EMT in carcinoma progression and
dissemination: Facts, unanswered questions, and clinical
considerations. Cancer Metastasis Rev. 31:277–283. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gomes LR, Terra LF, Sogayar MC and
Labriola L: Epithelial-mesenchymal transition: Implications in
cancer progression and metastasis. Curr Pharm Biotechnol.
12:1881–1890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Brabletz T: To differentiate or not-routes
towards metastasis. Nat Rev Cancer. 12:425–436. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamanaka Y, Wilson EM, Rosenfeld RG and Oh
Y: Inhibition of insulin receptor activation by insulin-like growth
factor binding proteins. J Biol Chem. 272:30729–30734. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q,
Lv B, Hu H, Lin J, Cui J, et al: IGFBP7 plays a potential tumor
suppressor role in colorectal carcinogenesis. Cancer Biol Ther.
6:354–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tamura K, Hashimoto K, Suzuki K, Yoshie M,
Kutsukake M and Sakurai T: Insulin-like growth factor binding
protein-7 (IGFBP7) blocks vascular endothelial cell growth factor
(VEGF)-induced angiogenesis in human vascular endothelial cells.
Eur J Pharmacol. 610:61–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Benatar T, Yang W, Amemiya Y, Evdokimova
V, Kahn H, Holloway C and Seth A: IGFBP7 reduces breast tumor
growth by induction of senescence and apoptosis pathways. Breast
Cancer Res Treat. 133:563–573. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Evdokimova V, Tognon CE, Benatar T, Yang
W, Krutikov K, Pollak M, Sorensen PH and Seth A: IGFBP7 binds to
the IGF-1 receptor and blocks its activation by insulin-like growth
factors. Sci Signal. 5:ra922012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zlobec I, Terracciano L, Jass JR and Lugli
A: Value of staining intensity in the interpretation of
immunohistochemistry for tumor markers in colorectal cancer.
Virchows Arch. 451:763–769. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Joyce JA and Pollard JW:
Microenvironmental regulation of metastasis. Nat Rev Cancer.
9:239–252. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Takeno A, Takemasa I, Doki Y, Yamasaki M,
Miyata H, Takiguchi S, Fujiwara Y, Matsubara K and Monden M:
Integrative approach for differentially overexpressed genes in
gastric cancer by combining large-scale gene expression profiling
and network analysis. Br J Cancer. 99:1307–1315. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gambaro K, Quinn MC, Cáceres-Gorriti KY,
Shapiro RS, Provencher D, Rahimi K, Mes-Masson AM and Tonin PN: Low
levels of IGFBP7 expression in high-grade serous ovarian carcinoma
is associated with patient outcome. BMC Cancer. 15:1352015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tomimaru Y, Eguchi H, Wada H, Kobayashi S,
Marubashi S, Tanemura M, Umeshita K, Kim T, Wakasa K, Doki Y, et
al: IGFBP7 downregulation is associated with tumor progression and
clinical outcome in hepatocellular carcinoma. Int J Cancer.
130:319–327. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liao TT and Yang MH: Revisiting
epithelial-mesenchymal transition in cancer metastasis: The
connection between epithelial plasticity and stemness. Mol Oncol.
11:792–804. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao H, Xu E, Liu H, Wan L and Lai M:
Epithelial-mesenchymal transition in colorectal cancer metastasis:
A system review. Pathol Res Pract. 211:557–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Heerboth S, Housman G, Leary M, Longacre
M, Byler S, Lapinska K, Willbanks A and Sarkar S: EMT and tumor
metastasis. Clin Transl Med. 4:62015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu S, Zhang J, Xu F, Xu E, Ruan W, Ma Y,
Huang Q and Lai M: IGFBP-rP1 suppresses epithelial-mesenchymal
transition and metastasis in colorectal cancer. Cell Death Dis.
6:e16952015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Georges RB, Adwan H, Hamdi H, Hielscher T,
Linnemann U and Berger MR: The insulin-like growth factor binding
proteins 3 and 7 are associated with colorectal cancer and liver
metastasis. Cancer Biol Ther. 12:69–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hooper AT, Shmelkov SV, Gupta S, Milde T,
Bambino K, Gillen K, Goetz M, Chavala S, Baljevic M, Murphy AJ, et
al: Angiomodulin is a specific marker of vasculature and regulates
vascular endothelial growth factor-A-dependent neoangiogenesis.
Circ Res. 105:201–208. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suzuki H, Igarashi S, Nojima M, Maruyama
R, Yamamoto E, Kai M, Akashi H, Watanabe Y, Yamamoto H, Sasaki Y,
et al: IGFBP7 is a p53-responsive gene specifically silenced in
colorectal cancer with CpG island methylator phenotype.
Carcinogenesis. 31:342–349. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Long TJ, Sprenger CC, Plymate SR and
Ratner BD: Prostate cancer xenografts engineered from 3D
precision-porous poly(2-hydroxyethyl methacrylate) hydrogels as
models for tumorigenesis and dormancy escape. Biomaterials.
35:8164–8174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hur K, Toiyama Y, Takahashi M, Balaguer F,
Nagasaka T, Koike J, Hemmi H, Koi M, Boland CR and Goel A:
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT)
in human colorectal cancer metastasis. Gut. 62:1315–1326. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Comaills V, Kabeche L, Morris R, Buisson
R, Yu M, Madden MW, LiCausi JA, Boukhali M, Tajima K, Pan S, et al:
Genomic instability is induced by persistent proliferation of cells
undergoing epithelial-to-mesenchymal transition. Cell Rep.
17:2632–2647. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sun Y, Campisi J, Higano C, Beer TM,
Porter P, Coleman I, True L and Nelson PS: Treatment-induced damage
to the tumor microenvironment promotes prostate cancer therapy
resistance through WNT16B. Nat Med. 18:1359–1368. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Creighton CJ, Li X, Landis M, Dixon JM,
Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A,
Herschkowitz JI, et al: Residual breast cancers after conventional
therapy display mesenchymal as well as tumor-initiating features.
Proc Natl Acad Sci USA. 106:13820–13825. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adam R, de Gramont A, Figueras J, Kokudo
N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L,
Sobrero A, et al: Managing synchronous liver metastases from
colorectal cancer: A multidisciplinary international consensus.
Cancer Treat Rev. 41:729–741. 2015. View Article : Google Scholar : PubMed/NCBI
|
